Target intelligence / Profile preview

E3 ubiquitin-protein ligase HUWE1 (HUWE1)

Target
HUWE1
Molecular classification
Enzyme, E3 ubiquitin ligase, HECT domain-containing protein
01

Overview

E3 ubiquitin-protein ligase HUWE1 is a large, multi-domain enzyme encoded by the HUWE1 gene on the human X chromosome. HUWE1 belongs to the HECT (homologous to E6AP carboxy terminus) family of E3 ubiquitin ligases and is capable of mediating ubiquitination of a wide range of protein substrates, including both tumor suppressors (such as p53, ATM, CDKN2A) and oncoproteins (such as c-Myc, Mcl-1). It features a distinctive ring-shaped architecture with armadillo repeat domains that facilitate substrate recognition and a C-terminal HECT catalytic domain for ubiquitin transfer. HUWE1 is essential for neuronal development and has roles in cell proliferation, DNA repair, apoptosis, and maintenance of proteostasis. Its dysregulation is implicated in several malignancies and neurodevelopmental disorders, with context-dependent roles in either promoting or suppressing tumorigenesis. No small-molecule drug modulators are currently in routine clinical use, though genetic and proteasomal targeting strategies have been explored in cancer models.

Other names
ARF-BP1MuleHECTH9HSPC272Ib772LASU1URE-B1UREB1HECTUBA and WWE domain containing protein 1HECT, UBA and WWE domain containing E3 ubiquitin ligase 1MRXST
02

Mechanism of action

Modulation of HUWE1 expression (gene therapy/CRISPR-based modulation for tumor suppression) Proteasome-mediated degradation via ubiquitination of oncogenic and tumor suppressor proteins

03

Biological functions

Ubiquitination and degradation of proteinsProtein quality control and proteostasisRegulation of cell proliferation and differentiationDNA damage responseRegulation of apoptosisRegulation of neural progenitor proliferation and nervous system development
04

Disease associations

Cancer (oncogenesis and tumor suppression)Glioblastoma and other brain tumorsIntellectual disability (genetic mutations implicated)Various other organ cancers (prostate, breast, colon, lung, gastric, laryngeal)Inflammatory diseases
05

Safety considerations

Therapeutic targeting of HUWE1 presents challenges due to its dual roles in both tumor suppression and oncogenic activityInvolvement in neural development and potential risk of disrupting essential protein homeostasis
06

Interacting drugs

none explicitly identified in search results; experimental approaches include gene therapy/CRISPR tools such as rAAV-CRISPR systems to modulate HUWE1 expression in glioblastoma
07

Biomarkers

Low expression of HUWE1 is associated with poor prognosis in glioblastomaHUWE1 gene mutations are monitored for intellectual disability and potential cancer predisposition

Beyond the preview

Go deeper on E3 ubiquitin-protein ligase HUWE1 (HUWE1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on E3 ubiquitin-protein ligase HUWE1 (HUWE1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call